EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio

Ashkan Khademi, Mohammad Hosein Sayahi, Cambyz Irajie, Vahid Haghpanah, Bagher Larijani, Mina Saeedi, Aida Iraji, Mohammad Mahdavi

RSC Advances · 2026

DOI: 10.1039/d6ra06870g ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Ashkan Khademi und 7 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Shiraz University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains one of the most commonly diagnosed malignancies worldwide, and developing novel cytotoxic agents that overcome therapeutic resistance remains a major priority in anticancer drug discovery.

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Khademi, A., Sayahi, M. H., Irajie, C., Haghpanah, V., Larijani, B., Saeedi, M., Iraji, A., & Mahdavi, M. (2026). Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio. RSC Advances. https://doi.org/10.1039/d6ra06870g

Vancouver

Khademi A, Sayahi MH, Irajie C, Haghpanah V, Larijani B, Saeedi M, et al. Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio. RSC Advances. 2026. doi:10.1039/d6ra06870g

BibTeX
@article{Khademi2026,
  author = {Khademi, Ashkan and Sayahi, Mohammad Hosein and Irajie, Cambyz and Haghpanah, Vahid and Larijani, Bagher and Saeedi, Mina and Iraji, Aida and Mahdavi, Mohammad},
  title = {Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio},
  journal = {RSC Advances},
  year = {2026},
  doi = {10.1039/d6ra06870g}
}
Kostenlos starten →